Items where Funder is Changzhou Kanghui Medical Innovation Co.
318553
Man, K, Mekhileri, NV, Lim, KS et al. (3 more authors) (2021) MI192 induced epigenetic reprogramming enhances the therapeutic efficacy of human bone marrows stromal cells for bone regeneration. Bone, 153. 116138. ISSN 8756-3282
N/A
Yang, X orcid.org/0000-0002-0144-2826, Mohanram, Y, Zhang, J et al. (2 more authors) (2022) BIOMIMETIC SCAFFOLD - ABM/P-15 FOR IMPROVING BONE REGENERATION SPEED AND EFFICACY: FROM DISCOVERY TO COMMERCIALISATION. In: TERMIS2021, 15-19 Nov 2021, Online.
No Ext Ref Given
Yang, X orcid.org/0000-0002-0144-2826, Mohanram, Y, Zhang, J et al. (2 more authors) (2022) BIOMIMETIC SCAFFOLD - ABM/P-15 FOR IMPROVING BONE REGENERATION SPEED AND EFFICACY: FROM DISCOVERY TO COMMERCIALISATION. In: TERMIS2021, 15-19 Nov 2021, Online.
Man, K, Mekhileri, NV, Lim, KS et al. (3 more authors) (2021) MI192 induced epigenetic reprogramming enhances the therapeutic efficacy of human bone marrows stromal cells for bone regeneration. Bone, 153. 116138. ISSN 8756-3282